MeSH D013736 - testicular neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Bleomycin | Bleomycin |  | 1996-06-01 |  |  |
| Etoposide | Etoposide |  | 1994-02-10 |  |  | |
| Ifosfamide, Mesna | Ifosfamide/mesna |  | 2002-02-26 |  |  | |
| Cyclophosphamide | Neosar |  | 1993-04-29 |  |  | |
| Oxaliplatin | Oxaliplatin |  | 2009-08-07 |  |  | |
| Etoposide | Toposar |  | 1995-02-27 |  |  | |
| Cisplatin | Cisplatin |  | 2000-05-16 |  |  | |
| Novast Laboratories | Oxaliplatin | Oxaliplatin |  | 2018-10-16 |  |  |
| Dr Reddys Laboratories | Cyclophosphamide | Cyclophosphamide | 2036-02-15 | 2020-07-30 |  |  |
| Mylan | Etoposide | Etoposide |  | 2001-09-19 |  |  |
| Oxaliplatin | Oxaliplatin |  | 2012-08-07 |  |  | |
| Cisplatin | Cisplatin |  | 2012-04-18 |  |  | |
| Methotrexate | Methotrexate |  | 1992-05-15 |  |  | |
| Rising Pharmaceuticals | Ifosfamide | Ifosfamide |  | 2012-11-26 |  |  |
| Methotrexate | Methotrexate |  | 2012-03-29 |  |  | |
| Cipla | Bleomycin | Bleomycin |  | 2019-03-11 |  |  |
| Cyclophosphamide | Cyclophosphamide |  | 2019-01-18 |  |  | |
| Sandoz | Oxaliplatin | Oxaliplatin |  | 2009-08-07 |  |  |
| Cyclophosphamide | Cyclophosphamide |  | 2023-09-12 |  |  | |
| Methotrexate | Methotrexate |  | 2009-03-31 |  |  | |
| Sanofi | Oxaliplatin | Eloxatin |  | 2002-08-09 |  |  |
| Eli Lilly | Vinblastine | Velban |  | 1982-01-01 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
75%6/8
Phase 2
19%5/27
Phase 3
82%14/17
Approved: 11Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use